Evidence map›Paper›PMID 28670688›Full record

ArticleImmunology2017

Lack of Ikaros cripples expression of Foxo1 and its targets in naive T cells.

Parul Agnihotri, Nicholas M Robertson, Sarah E Umetsu, Ksenia Arakcheeva, Susan Winandy

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. AIOLOS-Associated Inborn Errors of Immunity.Journal of clinical immunology · 2024
    Review
  3. Review
  4. Impaired tissue homing by the Ikzf3Frontiers in immunology · 2023
    Article
  5. Article
  6. Observational
  7. Lack of Ikaros Deregulates Inflammatory Gene Programs in T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Parul AgnihotriDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Nicholas M RobertsonDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Sarah E UmetsuDepartment of Microbiology-Immunology, Northwestern University, Chicago, IL, USA.
Ksenia ArakcheevaDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Susan WinandyDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0001-7804-9603
Boston University · USNorthwestern University · US

Funding

The Role of Ikaros in Regulatory T Cells that Protect Against Allergic AsthmaF30ES015971 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI UMETSU, SARAH · 2007 to 2011
$176k
NIEHS NIH HHS F30 ES015971
6 · The paper itself

Abstract

Ikaros is a transcription factor that regulates lymphocyte development from the level of the haematopoietic stem cell. Lack of Ikaros reduces the ability of progenitor cells to commit to the T-cell lineage, resulting in reduced numbers of early thymic T-cell progenitors and mature T cells. Mature CD4 T cells that lack Ikaros have defects in proliferation, T helper cell differentiation, cytokine expression and the ability to become anergic. A role for Ikaros in the naive T cell has not yet been identified. The receptors interleukin-7 receptor α (IL-7Rα) and l-selectin are important for ensuring survival and proper homing of naive T cells, respectively. Here we show that lack of Ikaros leads to reduced expression of these receptors in naive T cells, which impacts their ability to home and survive in response to IL-7. We define the mechanism underlying this phenotype as a requirement for Ikaros in maintenance of expression of Foxo1, a transcriptional regulator that is required for their expression. We also demonstrate that CD4 T cells lacking Ikaros are significantly crippled in their ability to become induced regulatory T cells, a phenotype also linked to reduced Foxo1 expression. Finally, we show that restoring Ikaros function to Ikaros-deficient CD4 T cells increases levels of Foxo1 message. Together, these studies define, for the first time, a role for Ikaros in naive T cells and establish it as the first transcriptional regulator required for maintaining levels of Foxo1 gene expression in these cells.

Indexed as

Adoptive TransferAnimalsCD4-Positive T-LymphocytesCell DifferentiationCells, CulturedCell SurvivalChemotaxis, LeukocyteForkhead Box Protein O1Gene Expression RegulationGenotypeIkaros Transcription FactorInterleukin-7L-SelectinMice, 129 StrainMice, Inbred BALB CMice, Inbred C57BLForkhead Box Protein O1Foxo1 protein, mouseIkaros Transcription FactorIl17ra protein, mouseInterleukin-7L-SelectinReceptors, Interleukin-17Zfpn1a1 protein, mouseFoxo1IkarosT celltranscription

Identifiers

PMID28670688
PMCPMC5629446
OpenAlexW2733247369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.